Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Biochem Biophys Res Commun. 2013 Jan 29;432(1):116–122. doi: 10.1016/j.bbrc.2013.01.075

Figure 2.

Figure 2

5-aza-dC (DNMTs inhibitor) treatment induces changes in morphology and invasion/migration capacity indicative of MET. A. Morphology of 5-aza-dC treated HTR8/SVneo cells. Original picture is 200X. The white lines indicate cell boundary. B. 5-aza-dC treatment compromises cell invasion and migration capabilities. Data is presented as mean ± SEM. Asterisk (*) denotes statistically significant differences between 5-aza-dC treatment vs. control group.